21st International Congress » Parkinson's Disease: Psychiatric Manifestations

Date: Wednesday, June 7, 2017

Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:15pm-2:45pm: Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

1:15pm-2:45pm: Baseline Clinical Predictors of Future Psychotic Symptoms in de novo Parkinson Disease

M. Barrett, M. Smolkin (Charlottesville, VA, USA)

1:15pm-2:45pm: Behavioral and psychological symptoms in Parkinson’s disease with SWEDDs

J. Ahn, H. Kim (Seoul, Republic of Korea)

1:15pm-2:45pm: Capgras syndrome in advanced Parkinson disease

C. Groth, A. Pusso, D. Huss, S. Sperling, B. Shah, M. Harrison, W.J. Elias, G.F. Wooten, M. Barrett (Charlottesville, VA, USA)

1:15pm-2:45pm: Compulsive sexual behaviour in Parkinson’s disease is associated with higher doses of levodopa

P. Barbosa, T. Warner, A. Djamshidian (London, United Kingdom)

1:15pm-2:45pm: Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.

S. Ray, D. Park, D. Burdick, A. Griffith, J. Shaw, P. Agarwal (Kirkland, WA, USA)

1:15pm-2:45pm: Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis

J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

1:15pm-2:45pm: Dopamine agonist therapy mediates relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease.

T. Turner, J. Renfroe, V. Hinson (Charleston, SC, USA)

1:15pm-2:45pm: Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease

N. Dissanayaka, T. Au, A. Angwin, J. O'Sullivan, G. Byrne, P. Silburn, R. Marsh, G. Mellick, D. Copland (Brisbane, Australia)

1:15pm-2:45pm: Genetics of impulse control disorders in Parkinson’s disease: a case control study

J.-C. Corvol, F. Cormier-Dequaire, S. Bekadar, S. Prud'hon, M. Anheim, J.-P. Azulay, F. Durif, J.-L. Houeto, A. Destée, K. Tahiri, G. Mangone, L. Lacomblez, P. Krack, P. Krystkowiak, D. Maltête, O. Rascol, C. Tranchant, M. Vidailhet, A. Brice, S. Tezenas duMontcel (Paris, France)

1:15pm-2:45pm: Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study

N. Dissanayaka, N. Pachana, J. O'Sullivan, R. Marsh, P. Silburn, E. White, E. Torbey, D. Pye, L. Mitchell, J.H. Yang, T. Au, G. Mellick, D. Copland, A. Toft, G. Byrne (Brisbane, Australia)

1:15pm-2:45pm: Impulse Control Disorders in Parkinson’s Disease: Prevalence and Clinical Features in the Rush University Movement Disorders Clinic

M. Rossi, G. Stebbins, B. Barton (Chicago, IL, USA)

1:15pm-2:45pm: Longitudinal analysis of the relation of dopamine agonist use with impulse control disorders in Parkinson’s disease

j.-c. corvol, F. Artaud, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, f. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, v. Mesnage, P.C. Lee, A. Brice, M. Vidailhet, F. Cormier-Dequaire, A. Elbaz (Paris, France)

1:15pm-2:45pm: Minor hallucinations in Parkinson’s disease: neuropshycological and neurophysiological correlates in a representative sample of non-demented patients.

J. Pagonabarraga, J. Marin-Lahoz, A. Horta, H. Bejr-Kasem, M. Cornella, J. Pérez-Pérez, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

1:15pm-2:45pm: Othello syndrome amongst patients with Parkinson’s disease in a rural movement disorders clinic in western India

S. Desai, D. Desai (Anand, India)

1:15pm-2:45pm: Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality

J. Hinkle, K. Perepezko, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

1:15pm-2:45pm: Predictors of onset of psychosis in Parkinson’s disease: “Who gets it early?”

P. Pal, A. Lenka, L. George, S. Arumugham, S. Hegde, N. Kamble, R. Yadav (Bangalore, India)

1:15pm-2:45pm: Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease

R. Alugolu, M.B. Kesani, B. Ganji, V. Mudumba, R. Mrudula, R. Borgohain, P. Gaddamanugu (Hyderabad, India)

1:15pm-2:45pm: Suicidality in Parkinson’s Disease: A Case Control Study

M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga (Ankara, Turkey)

1:15pm-2:45pm: Systematic Evaluation of Major and Minor Psychotic Symptoms in Parkinson’s Disease

C. Kulick, K. Montgomery, M. Nirenberg (New York, NY, USA)

1:15pm-2:45pm: The role of habenula and amygdala dysfunction in Parkinson’s disease patients with punding

V. Markovic, F. Agosta, E. Canu, A. Inuggi, I. Petrovic, I. Stankovic, F. Imperiale, T. Stojkovic, V. Kostic, M. Filippi (Belgrade, Serbia)

1:15pm-2:45pm: Treatment of Parkinson’s disease psychosis–a systematic review of RCTs

K. Cook, D. Nellesen, K. Adamski, A. Shim (Menlo Park, CA, USA)

1:15pm-2:45pm: Treatment of Psychosis in Parkinson’s Disease: Evidence-Based Recommendations Versus Actual Clinical Practice

L.G. Chan, A. Kong, L. Tan (Singapore, Singapore)

1:15pm-2:45pm: What do patients with Parkinson’s disease see in their hallucinations? Classification of hallucinations which are seen in Parkinson’s Disease; Single Center Experience

A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

« View all sessions from the 21st International Congress.